Hypertension. 1995;26:1070-1073
(Hypertension. 1995;26:1070-1073.)
© 1995 American Heart Association, Inc.
Calcium-ATPase and Insulin in Adolescent Offspring of Essential Hypertensive Parents
Beatriz Grunfeld;
María Gimenez;
Miriam Romo;
Laura Rabinovich;
Rosa B. Simsolo
From the Hypertension Clinic, Children's Hospital "Ricardo
Gutierrez," Buenos Aires, Argentina.
Correspondence to Beatriz Grunfeld, MD, Hipertensión Arterial, Hospital de Niños "R. Gutierrez," La Pampa 3635, 1430 Buenos Aires, Argentina.
 |
Abstract
|
|---|
Abstract A number of abnormalities in calcium homeostasis
have
been reported in patients with essential hypertension. In turn,
insulin
has been shown to influence the activity of the
Ca
2+-ATPase.
We have previously shown that
normotensive offspring of essential
hypertensive individuals have an
exaggerated insulin response
to a glucose overload. Therefore, the aim
of the present study
was to evaluate basal and
calmodulin-activated
Ca
2+-ATPase in
red blood cells and its relationship
to the insulin response
during an intravenous glucose
tolerance test in 27 normotensive
adolescents with a family history of
essential hypertension
(F+) (mean age, 13.9±0.5 years) and in 10
control subjects
matched for age and body mass index with no family
history of
hypertension (F-). The results (mean±SD) were as
follows
(µmol Pi/[mg protein/h]10
-1):
basal Ca
2+-ATPase, 4.5±1.2
in F+ and 5.1±1.6 in
F- (
P=NS);
calmodulin-activated
Ca
2+-ATPase,
13.6±3.9 in F+ and 16.2±1.7 in
F- (
P<.04).
The insulin area under the curve after
the glucose load was
3413±1674 µU/mL per hour in F+ and 2752±928
in
F- (
P=NS).
Calmodulin-activated
Ca
2+-ATPase showed a negative
correlation with
the insulin area under the curve (
r=-.59,
P<.005)
and cholesterol levels
(
r=-.38,
P<.03). Urinary calcium excretion
was
1.82±0.9 mmol/d in F+ and 2.47±0.9 mmol/d in F-
(
P=NS).
Our findings indicate a diminished activity of
calmodulin-stimulated
Ca
2+-ATPase
despite increased levels of insulin, a known activator
of
this pump, further suggesting the presence of insulin resistance
in
normotensive offspring of essential hypertensive individuals.
Since
Ca
2+-ATPase is an extrusion pump, a drop in its
activity
may lead to an increase in intracellular calcium
accumulation
and thus contribute to the development of
hypertension.
Key Words: hypertension, essential adolescent medicine Ca2+-transporting ATPase insulin
 |
Introduction
|
|---|
Anumber of
disturbances in calcium metabolism have been
reported
in arterial hypertension.
1 2 Lower
serum ionized calcium levels,
increased urinary excretion of calcium,
raised intracellular
calcium levels, and decreased
Ca
2+-ATPase or calmodulin-stimulated
Ca
2+-ATPase
activities have been shown in
platelets and erythrocytes obtained
from primary hypertensive
subjects.
3 4 5 6 7
Abnormalities in plasma membranes of vascular smooth muscle,
erythrocytes, and other cells have been reported in spontaneously
hypertensive rats, indicating that the disturbance in cellular
Ca2+ homeostasis seen in hypertension is not
confined to one tissue but represents a more generalized
defect.8 Studies on cellular calcium handling in
erythrocytes and platelets from primary hypertensive subjects have
suggested that the membrane defect relates to calcium efflux
mechanisms.9 10 Since Ca2+-ATPase is an
extrusion pump, a diminished activity would lead to intracellular
calcium accumulation and thus contribute to increased
peripheral vascular resistance and the development of
hypertension.
Insulin is known to have a significant effect on several
transmembrane ion-exchange systems, including
Na+-K+-ATPase and
Na+-H+ exchanger, and to directly stimulate
Ca2+-ATPase activity in kidney, heart, liver, and
adipocytes by increasing membrane calmodulin content and/or
phosphorylation or by increasing the enzyme affinity
for calcium.11 12 13 14
We and other researchers have previously shown that normotensive
offspring of primary hypertensive individuals have an abnormal insulin
response to a glucose challenge.15 Therefore, the aim of
the present study was to evaluate Ca2+-ATPase
and calmodulin-activated
Ca2+-ATPase in red blood cell membranes and their
relationship to the insulin response to an intravenous
glucose load in normotensive adolescents with and without a family
history of primary hypertension.
 |
Methods
|
|---|
Included in the study were 27 normotensive adolescents with
a
family history of primary hypertension (F+) (mean age, 13.9±0.5
years;
range, 12 to 19 years; 10 females; at least one parent
with
long-standing hypertension as assessed by one of the authors)
and
10 normotensive control subjects (mean age, 13.7±0.7
years; range, 12
to 19 years; 4 females) without a family history
of hypertension
(F-). All participants were healthy; were taking
no medications;
were white, from Spanish or Italian background;
and were matched for
age, body mass index, and pubertal stage
(Tanner stages III and
IV).
Procedures were carefully explained to both parents and children, and
informed consent was obtained from parents.
All subjects came to the Hypertension Clinic after an overnight fast
with a 24-hour urinary collection. A butterfly-like needle was
placed in an antecubital vein, and a blood specimen was obtained for
measurement of plasma glucose, insulin, cholesterol,
high-density lipoprotein cholesterol,
triglycerides, and Ca2+-ATPase and
calmodulin-stimulated Ca2+-ATPase
activities in red blood cell membranes. A glucose load (0.25 g/kg IV)
as a 25% solution was then infused over approximately 2 minutes into a
contralateral vein. Blood samples were obtained at 1, 3, 5, and 7
minutes after glucose injection for measurement of insulin and at 10,
20, 30, 40, 50, and 60 minutes for insulin and glucose.
Insulin was measured by radioimmunoassay.16 Calcium was
measured in a 24-hour urinary collection by an atomic absorption
spectrophotometer (Perkin-Elmer). Completeness of the collection was
evaluated by measurement of urinary creatinine.
Preparation of Isolated Red Blood Cell Membranes
One volume of red blood cells (washed three times with 150
mmol/L NaCl) was lysed in 8 vol lysing solution (1 mmol/L EGTA, 15
mmol/L Tris-HCl [pH 7.4], 1.4 mmol/L 2-mercaptoethanol) at 4°C.
Membranes were spun down at 10 000g during 20 minutes and
then washed twice with lysing solution. The membranes were then
suspended in 8 vol lysing solution, incubated 15 minutes at 37°C in
this solution, and spun down at 10 000g for 20 minutes.
This step was repeated once. Membranes were then washed with 8 vol of
15 mmol/L Tris-HCl (pH 7.4), resuspended in 1 vol of the same solution,
and stored at -20°C. This procedure yields membranes devoid of
endogenous calmodulin.
Ca2+-ATPase Activity
ATPase activity was measured at 37°C in a medium containing
(mmol/L) KCl 120, Tris-HCl (pH 7.4 at 37°C) 30, MgCl2 4,
EGTA 1, and ATP and CaCl2 2. Ca2+-ATPase
activity was taken as the difference between the activity measured in
the above medium and that measured in the same medium without
calcium.17
Statistical Analysis
Samples were analyzed with the unpaired t
test. Pearson correlation coefficients and stepwise multiple linear
regression analysis were used for assessment of relations
between variables. A value of P<.05 was accepted as
significant. Findings are expressed as mean±SD.
 |
Results
|
|---|
The clinical findings of the subjects are shown in the
Table
.
There were no significant differences in body
mass index, cholesterol
levels, and systolic and
diastolic blood pressures between adolescents
with or
without a family history of hypertension.
Ca2+-ATPase was comparable in both groups (4.5±1.2
µmol Pi/[mg protein/h]10-1 in F+ and
5.1±1.6 in F-; P=NS) (Fig 1). Calmodulin-stimulated
Ca2+-ATPase was significantly lower in adolescents
with a family history of hypertension than in those without a family
history of hypertension (13.6±3.9 µmol Pi/[mg
protein/h]10-1 in F+ and 16.2±1.7 in
F-; P<.04) (Fig 2). The
insulin area under the curve after the intravenous glucose
load was comparable in both groups (3413±1674 µU/mL per hour in F+
and 2752±928 in F-; P=NS).

View larger version (25K):
[in this window]
[in a new window]
|
Figure 1. Bar graph shows Ca2+-ATPase
activity in adolescents with (F+) and without (F-) a family
history of hypertension.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Figure 2. Bar graph shows
calmodulin-activated
Ca2+-ATPase activity in adolescents with (F+) and
without (F-) a family history of hypertension.
*P<.05.
|
|
Calmodulin-stimulated Ca2+-ATPase
was negatively correlated to both the insulin area under the curve
(r=-.59, P<.005) (Fig 3) and serum cholesterol
levels (r=-.38, P<.03) (Fig 4). Stepwise multiple linear regression
analysis suggested that the insulin area under the curve may
account for up to 36% of the variation in
calmodulin-stimulated Ca2+-ATPase.
When cholesterol was added to the model, the overall
prediction equaled 42%. Urinary calcium excretion was comparable in
both groups (1.82±0.9 mmol/d in F+ and 2.47±0.9 in F-).

View larger version (14K):
[in this window]
[in a new window]
|
Figure 3. Graph shows relationship between
calmodulin-activated
Ca2+-ATPase activity and insulin area under the
curve in adolescents with (F+) and without (F-) a family history
of hypertension (r=-.59, P<.005).
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Figure 4. Graph shows relationship between
calmodulin-activated
Ca2+-ATPase activity and cholesterol
levels in adolescents with (F+) and without (F-) a family history
of hypertension (r=-.38, P<.03).
|
|
 |
Discussion
|
|---|
Abnormalities in serum insulin levels and calcium
metabolism
have been reported in primary hypertensive
subjects. However,
it is not clear whether these changes precede the
development
of hypertension or are a consequence of high blood
pressure.
Our findings indicate that normotensive adolescent offspring of primary
hypertensive individuals have decreased
calmodulin-stimulated Ca2+-ATPase
activity, which is negatively correlated to both circulating insulin
and cholesterol levels. A diminished
Ca2+-ATPase or calmodulin-stimulated
Ca2+-ATPase has been demonstrated in platelets
and erythrocytes obtained from primary hypertensive
subjects.6 10 18
Slightly reduced serum calcium and significantly raised plasma
parathyroid hormone levels were also observed in prehypertensive young
subjects genetically at risk for hypertension, supporting the view that
disturbances in calcium metabolism are present
in the early phase of primary hypertension and may precede the
development of high blood pressure.19
Since Ca2+-ATPase is an extrusion pump, a diminished
activity would lead to an intracellular calcium accumulation in
vascular smooth muscle cells, and this may be of primary importance in
the origin of increased peripheral vascular resistance, a
characteristic feature of the hypertensive state. The reduced
vasodilator response observed in obese adolescents that correlated with
the degree of insulin resistance may be an expression of these
findings.20
The abnormalities of intracellular calcium homeostasis described in
this report may not be attributed directly to changes in
calmodulin because calmodulin content and
distribution in red blood cells from hypertensive subjects have been
reported to be normal.10
Insulin is known to have significant effects on several transmembrane
ion-exchange systems, including Na,K-ATPase and Na-H exchanger, and
to directly stimulate Ca2+-ATPase activity in
kidney, heart, liver, and adipocytes by increasing membrane
calmodulin content and/or phosphorylation
or by increasing the enzyme affinity for calcium.11 12 13 21
Since we found a decreased calmodulin-stimulated
Ca2+-ATPase activity in the presence of high insulin
levels, our data indicate the presence of insulin resistance and reveal
still another link between abnormal insulin glucose
metabolism and high blood pressure.
We have found decreased calmodulin-stimulated
Ca2+-ATPase activity negatively correlated to
increased serum cholesterol levels. It has been shown that
the basal activity of Ca2+-ATPase as well as its
response to calmodulin or to hormonal regulation depends in
part on the lipid milieu.22 23 Abnormalities have also
been previously described in human primary hypertension in other
membrane transport systems, such as the Na,K-ATPase, Na-Li
countertransport, and Na-H antiporter.24
Whatever the mechanisms involved, the above-described abnormalities
in insulin, cholesterol, and Ca2+-ATPase
activity as well as in sodium transport may be an expression of a
widespread plasma membrane defect that precedes and may contribute to
the development of high blood pressure.
 |
Acknowledgments
|
|---|
This work was supported by grant CONICET PID 3340/92. We are
thankful
to Fernando Rubinstein, MD, for his valuable advice in
statistical
matters.
Received June 19, 1995;
first decision August 1, 1995;
accepted August 18, 1995.
 |
References
|
|---|
-
Lau K, Eby B. The role of calcium in
genetic hypertension. Hypertension. 1985;7:657-667. [Free Full Text]
-
McCarron DA. Calcium metabolism and
hypertension. Kidney Int. 1989;35:717-736. [Medline]
[Order article via Infotrieve]
-
McCarron D, Morris C, Henry H, Staton J. Blood
pressure and nutrient intake in the United States.
Science. 1984;224:1392-1398. [Abstract/Free Full Text]
-
McCarron D, Pingree P, Rubin R, Gaucher S, Krutzik
S. Enhanced parathyroid function in primary hypertension: an
homeostatic response to a urinary calcium leak.
Hypertension. 1984;2:162-168 [Abstract/Free Full Text]
-
Strazzullo P, Nunziata V, Cirillo M, Giannattasio R,
Ferrara LA, Mattioli PL, Mancini M. Abnormalities of calcium
metabolism in essential hypertension. Clin
Sci. 1983;65:137-141. [Medline]
[Order article via Infotrieve]
-
Vincenzi F, Morris C, Kinsel L, McCarron D.
Decreased calcium pump adenosine triphosphatase in red blood
cells of hypertensive subjects.
Hypertension. 1986;8:1058-1066. [Abstract/Free Full Text]
-
Resink TJ, Tkachuk VA, Erne P, Buhler FR.
Platelet membrane calmodulin-stimulated
calcium-adenosine triphosphatase: altered activity in
essential hypertension. Hypertension. 1986;8:159-166. [Abstract/Free Full Text]
-
Pershadsingh HA, McDonald JM. A high affinity
calcium-stimulated magnesium-dependent adenosine
triphosphatase in rat adipocyte plasma membranes. J
Biol Chem. 1980;255:4087-4093. [Free Full Text]
-
Erne P, Bolli P, Burgiser E, Buhler F.
Correlation of platelet calcium with blood pressure effect of
antihypertensive therapy. N Engl J Med. 1984;310:1084-1088. [Abstract]
-
Postnov YV, Orlov S, Reznikova M, Pokudin N.
Calmodulin distribution and calcium transport in the
erythrocytes of patients with essential hypertension.
Clin Sci. 1984;66:459-463. [Medline]
[Order article via Infotrieve]
-
Levy J, Gavin JR III, Hammerman MR, Avioli LV.
Ca Mg ATPase activity in kidney basolateral membrane in
non-insulin-dependent diabetic rats: effects of
insulin. Diabetes. 1986;35:899-905. [Abstract]
-
Levy J, Gavin JR III, Hammerman MR, Avioli LV.
Hormonal regulation of
(Ca2++Mg2+) ATPase activity in
canine renal basolateral membrane. Endocrinology. 1986;119:2405-2411. [Abstract]
-
Pershadsingh HA, McDonald JM. Direct addition of
insulin inhibits a high affinity Ca-ATPasa in isolated adipocyte plasma
membrane. Nature. 1979;281:495-497. [Medline]
[Order article via Infotrieve]
-
Hope-Gill HF, Nanada V. Stimulation of calcium
ATPase by insulin, glucagon, cyclic AMP and cyclic GMP in Triton X-100
extracts of purified rat liver plasma membrane. Horm
Metab Res. 1979;11:698-700.[Medline]
[Order article via Infotrieve]
-
Grunfeld B, Balzaretti M, Romo M, Gimenez M, Gutman
R. Hyperinsulinemia in normotensive
offspring of hypertensive parents.
Hypertension. 1994;23(suppl I):I-12-I-15.
-
Desbuquiois B, Aurbach GD. Use of
polyethyleneglycol to separate free and antibody peptide hormones in
radioimmunoassay. J Clin Endocrinol. 1971;33:732-735. [Medline]
[Order article via Infotrieve]
-
Rossi JP, Delfino J, Caride A, Fernandez H.
Interaction of unsaturated fatty acid with the red blood cell
Ca2+-ATPase: studies with a novel photoactivatable
probe. Biochemistry. 1995;34:3802-3812. [Medline]
[Order article via Infotrieve]
-
Resink TJ, Tkachuk VA, Erne P, Buhler FR.
Platelet membrane calmodulin-stimulated
calcium-adenosine triphosphatase: altered activity in
essential hypertension. Hypertension. 1986;8:159-166.
-
van Hooft IMS, Grobbee DE, Frolich M, Pols H, Hofman
A. Alterations in calcium metabolism in young people
at risk for primary hypertension: the Dutch hypertension and offspring
study. Hypertension. 1993;21:267-272. [Abstract/Free Full Text]
-
Rocchini AP, Moorehead CV, Katch V, Key J, Finta
K. Forearm resistance vessel abnormalities and insulin
resistance in obese adolescents.
Hypertension. 1992;19:615-620. [Abstract/Free Full Text]
-
Goewert RR, Klaven NB, McDonald JM. Direct
effect of insulin on the binding of calmodulin adipocyte
plasma membranes. J Biol Chem. 1983;258:9995-9999. [Abstract/Free Full Text]
-
Warren GB, Houslay MD, Metcalfe JC, Birdsall NJ.
Cholesterol is excluded from the phospholipid annulus
surrounding an active calcium transport protein.
Nature. 1975;255:684-687. [Medline]
[Order article via Infotrieve]
-
Ortega A, Mas-Oliva J. Direct regulatory effect
of cholesterol on the calmodulin stimulated
calcium pump of cardiac sarcolemma. Biochem Biophys Res
Commun. 1986;139:868-874. [Medline]
[Order article via Infotrieve]
-
Gimenez M, Grunfeld B, Simsolo R, Oyhhamburu J,
Becú L. Sodium transport systems in red cell membranes and
plasma lipids in the hypertensive and normotensive offspring of
patients with essential hypertension. Pediatr Res. 1987;22:369. Abstract.